Bluejay Therapeutics

Deploy patient's own immune responses to cure chronic HBV infection

Our Mission

The mission of Bluejay is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection

Our Focus

Focus on reduction of HBs antigen (HBsAg) and restoration of adaptive immunity

/

About Us

The mission of Bluejay is to develop innovative cures for infectious diseases with the first target indication of chronic HBV infection.

Bluejay exclusively licensed the global rights to three assets that are best-in-class or first-in-class.

Bluejay is to develop new treatments for functional cure of chronic HBV infection.

More About Us

More than 250 MILLION

people have been chronically infected with hepatitis B virus (CHBV) WORLDWIDE AND 850,000 PEOPLE DIE EVERY YEAR FROM CHBV AND RELATED LIVER DISEASES
BJT pipeline

CAREER OPPORTUNITIES

Bluejay Therapeutics is always searching for talented individuals to join our team. For career opportunities & information, click below to find out what positions are currently available.

Openings